DrugRisk Update: Judge Orders Pradaxa Maker to Disclose Prior Lawsuit Info

Share Article

The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

DrugRisk Dangerous Drugs
Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible.

The prescription drug resource center DrugRisk.com is alerting patients taking the blood thinner Pradaxa that new information has been added to the site showing the judge presiding over Pradaxa internal bleeding lawsuits has ordered the drug maker to disclose information on prior lawsuits.

The goal of DrugRisk is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. “Many follow litigation to learn how others may be affected with similar problems and whether they have options,” explains DrugRisk representative Ryan Mayer.

DrugRisk previously added a report from the Institute for Safe Medication Practices showing anticoagulants like Pradaxa are among the highest risk outpatient drugs. Also, hemorrhage cases submitted to the FDA show bleeding from Pradaxa was nearly 5 times as likely to result in death than with warfarin.*

The resource center has learned that, due to the number of Pradaxa lawsuits filed so far, cases are being consolidated in a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. Judge David Herndon, who is overseeing the litigation, recently reported that as many as 176 cases have been filed.**

On January 19th, Judge Herndon signed an order denying attempts by Pradaxa maker Boehringer Ingelheim to protect information on prior lawsuits regarding false promotion, marketing or kickbacks for their drugs.***

Information on DrugRisk shows experts disagree about the safety of Pradaxa and its bleeding risks. While there has yet to be a Pradaxa recall, the FDA recently issued an update that the drug carries the same risks as warfarin.**** However, the Americal College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.*****

Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
**madisonrecord.com/issues/895-product-liability/251351-herndon-reports-steady-progress-in-yaz-pradaxa-litigation
***ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2251290.0.pdf#search=%22pradaxa%22
****fda.gov/Drugs/DrugSafety/ucm326580.htm
***** http://content.onlinejacc.org/article.aspx?articleid=1206384

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website